Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 we » 1_ we (Expand Search), 10 re (Expand Search), 16 we (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 we » 1_ we (Expand Search), 10 re (Expand Search), 16 we (Expand Search)
-
341
-
342
-
343
Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX
Published 2022“…</p><p>Conclusion:CLEC16A variants conferred a decreased risk to AR in the Chinese population.…”
-
344
Table1_CLEC16A variants conferred a decreased risk to allergic rhinitis in the Chinese population.DOCX
Published 2022“…</p><p>Conclusion:CLEC16A variants conferred a decreased risk to AR in the Chinese population.…”
-
345
Retinoic acid alleviates decreases of phospho-Akt and phospho-Bad expression caused by MCAO damage.
Published 2024“…Molecular weight (kDa) are depicted at right. Data (<i>n</i> = 5) are represented as mean ± S.E.M. *<i>p</i> < 0.001, **<i>p</i> < 0.01 vs. vehicle + sham animals, #<i>p</i> < 0.01 vs. vehicle + MCAO animals.…”
-
346
-
347
-
348
-
349
-
350
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae
Published 2025“…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
-
351
-
352
-
353
-
354
-
355
-
356
-
357
-
358
-
359
-
360